Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.

Authors:
Ren Y; Liang H; Huang Y; Miao Y; Li R and 11 more

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1341255

PMCID:
PMC10920334

PMID:
38464517

Journal Information

Journal Title: Front Immunol

Detailed journal information not available.

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the dataset included 12 gene expression profile samples all obtained using the gpl6244 affymetrix human gene 1 0 st array platform 2 4 2 deg identification was done using the geo2r online tool in geo which uses the geoquery and limma packages in r the screening criteria for degs were p < 0 05 and | logfc | > 3 2 4 3 david ( https://david ncifcrf gov/ ) was used for gene ontology (go) and kyoto encyclopedia of genes and genomes (kegg) analyses using p < 0 05 as the threshold 2 4 4 ppi networks of the degs were generated with string (version: 10 0; http://www string-db org/ ) with a ppi score threshold of 0 4 indicating medium confidence."

Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the Major Research Plan of National Natural Science Foundation of China (Grant Number: 92163213), General Program of National Natural Science Foundation of China (Grant Number: 81970085), Tianjin science and technology plan project (Grant Number: 21JCZDJC00940) and Tianjin health science and technology projects (Grant Number: TJWJ2022XK001). This work was supported funded by Tianjin Key Medical Discipline (Specialty) Construction Project (Grant Number: TJYXZDXK-006A). This work was supported by grants from National Key Research and Development Program of China (2020YFE0203000), National Natural Science Foundation of China (81890990, 82270148) and CAMS Innovation Fund for Medical Sciences (2022-I2M-2-003)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025